|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Novartis , Gerry Chader , Jamie A. GoodePublisher: John Wiley and Sons Ltd Imprint: John Wiley & Sons Ltd Volume: No. 255 Dimensions: Width: 16.50cm , Height: 1.60cm , Length: 23.70cm Weight: 0.498kg ISBN: 9780470853573ISBN 10: 0470853573 Pages: 226 Publication Date: 05 December 2003 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Unknown Availability: Awaiting stock ![]() Table of ContentsChair's Introduction (Shomi S Battacharya). Gene therapy of retinal dystrophies: Achievements, challenges and prospects (Dean Bok). Identifying retinal disease genes: how far have we come, how far do we have to go? (Stephen P Daiger). Dominant cone and cone-rod dystrophies: functional analysis of mutations in regGC1 and GCAP1 (David Hunt, Susan E Wilkie, Richard Newbold, Evelyne Deery, Martin J Warren, Shomi S Battacharya, and Kang Zhang). Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration (Roxana A Radu, Nathan L Mata, Steven Nusinowitz, Xinran Liu, and Gabriel H Travis). The expanding roles of ABCA4 and CRB1 in inherited blindness (F P M Cremers, A Maugeri, A I den Hollander, and C B Hoyng). What should a clinician know to be prepared for the advent of treatment of retinal dystrophies? (Alan C Bird). Role of subunit assembly in autosomal dominant retinitis pigmentosa link ed to mutations in perpherin 2 (Robert S Molday, Laurie L Molday, and Christopher J R Loewen). The search for rod-dependent cone viability factors, secretedd factors promoting cone viability (Thierry Leveillard, Saddek Mohand-Said, Anne-Claire Fintz, George Lambrou, and Jose-Alain Sahel). Studies on retinal and retinal pigment epithelial gene expression (Itay Chowers, Noriko Esumi, Peter Campochiaro, and Donald J Zack). From disease genes to cellular pathways: a progress report (J Yu, A J Mears, S Yoshida, R Farjo, T A Carter, D Ghosh, A Hero, C Barlow, and A Swaroop). Prospects for gene therapy (Robin R Ali). Range of retinal diseases potentially treatable by AAV-vectored gene therapy (William S Hauswirth, Quihong Li, Brian Raisler, Adrian M Timmers, Kenneth I Berns, John G Flannery, Matthew M LaVail, and Alfred S Lewin). Gene therapy for Leber congenital amaurosis (Jean Bennett). Index of Contributors. Subject Index.Reviews"""...as a broad perspective...it is a valuable text..."" (The Biochemist Online, 15 June 2004)" ...as a broad perspective...it is a valuable text... (The Biochemist Online, 15 June 2004) ""...as a broad perspective...it is a valuable text..."" (The Biochemist Online, 15 June 2004) Author InformationThe Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research. Tab Content 6Author Website:Countries AvailableAll regions |